Fresenius Medical Care AG & Co. KGaA

Factors to consider:

• Company pays dividends (annually): last record date 2026-05-25, amount 1.73$ (Y3.88%)
• Total employees count: 109698 (-1.6%) as of 2025
• Earnings for 6 months up through Q2 exceed our estimates

Stock Forecast*

* forecast is subjective and experimental, should not be used for any investment decisions

Long term estimates were made for the period from 2025-12-31 to 2027-12-31

• 2025-12-31 to 2026-12-31 estimated range: [40.31$, 58.79$]
• 2026-12-31 to 2027-12-31 estimated range: [42.39$, 61.63$]

Financial Metrics affecting the FMCQF estimates:

• Positive: with PPE of 9.4 at the end of fiscal year the price was neutral
• Positive: 15.29 < Operating cash flow per share per price, % of 23.25
• Positive: 7.80 < Operating profit margin, % of 9.36
• Positive: 1.88 < Return on assets ratio (scaled to [-100,100]) of 3.06
• Positive: -7.11 < Investing cash flow per share per price, % of -6.01
• Positive: Interest expense per share per price, % of 3.34 <= 4.56
• Positive: 42.26 < Shareholder equity ratio, % of 42.93 <= 49.86
• Negative: Industry earnings per price (median), % of 0 <= 0
• Negative: 0 < Industry inventory ratio change (median), % of 0